ORAI3 and prostate carcinoma: Dubois et al. [67] showed that varying Orai1/Orai3 ratios modulate the function of SOCE and basal cytosolic Ca2+ level, and Orai3 overexpression stimulates cell proliferation and promotes apoptosis resistance in prostate cancer cells.